ECT in the treatment of the catatonic syndrome

Rohland, Barbara M.; Carroll, Brendan T.; Jacoby, Robert G.

doi:10.1016/0165-0327(93)90015-c

Cited by 136 publications

(50 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…ECT is effective for various conditions and is a viable treatment option when pharmacotherapy and psychotherapy have failed, when affective, psychotic or catatonic symptoms are present, and when rapid relief of symptoms is required because of suicide risk or deterioration of medical conditions [1][2][3][4][5][6] . ECT is most commonly used for the treatment of severe depression, but is also effective for the treatment of manic or mixed episodes [7][8][9] .…”

Section: Introductionmentioning

confidence: 99%

Continuation and Maintenance Electroconvulsive Therapy for Mood Disorders: Review of the Literature

et al. 2011

View full text Add to dashboard Cite

Background: Electroconvulsive therapy (ECT) is a highly effective treatment for mood disorders. Continuation ECT (C-ECT) and maintenance ECT (M-ECT) are required for many patients suffering from severe and recurrent forms of mood disorders. This is a review of the literature regarding C- and M-ECT. Methods: We conducted a computerized search using the words continuation ECT, maintenance ECT, depression, mania, bipolar disorder and mood disorders. We report on all articles published in the English language from 1998 to 2009. Results: We identified 32 reports. There were 24 case reports and retrospective reviews on 284 patients. Two of these reports included comparison groups, and 1 had a prospective follow-up in a subset of subjects. There were 6 prospective naturalistic studies and 2 randomized controlled trials. Conclusions: C-ECT and M-ECT are valuable treatment modalities to prevent relapse and recurrence of mood disorders in patients who have responded to an index course of ECT. C-ECT and M-ECT are underused and insufficiently studied despite positive clinical experience of more than 70 years. Studies which are currently under way should allow more definitive recommendations regarding the choice, frequency and duration of C-ECT and M-ECT following acute ECT.

show abstract

Section: Introductionmentioning

confidence: 99%

Continuation and Maintenance Electroconvulsive Therapy for Mood Disorders: Review of the Literature

et al. 2011

View full text Add to dashboard Cite

show abstract

“…3 The ECT has a fundamental role in the resolution of catatonic symptoms. 4 NMS is a neurotoxic state that may be fatal. It occurs in about 0.2% of patients managed with neuroleptic drugs.…”

Section: Discussionmentioning

confidence: 99%

Uso de olanzapina e eletroconvulsoterapia em um paciente com esquizofrenia catatônica refratária e antecedentes de síndrome neuroléptica maligna

Alvarenga¹,

Rigonatti

2005

Rev. psiquiatr. Rio Gd. Sul

View full text Add to dashboard Cite

Este artigo descreve a história clínica e o manejo de um paciente masculino adulto com esquizofrenia catatônica refratária a dois neurolépticos típicos (haloperidol e clorpromazina) e a outro agente atípico (risperidona), e com antecedente de dois episódios de síndrome neuroléptica maligna em vigência de neurolépticos típicos. Os autores optaram pela associação de eletroconvulsoterapia (ECT) e olanzapina (7,5 mg). Foram obtidos consideráveis benefícios para o paciente.

show abstract

“…[20] Bush et al and Fink showed that ECT is effective in relieving catatonia after failure of using 6-16 mg/day lorazepam for up to 5 days. [21] ECT is a safe treatment, although serious complications including status epilepticus, prolonged seizure, postictal agitation, cardiovascular compromise, and pulmonary embolism are reported infrequently.…”

Section: What This Study Adds To the Fieldmentioning

confidence: 99%